Efficacy of Erlotinib plus dendritic cells and cytokine-induced killer cells in maintenance therapy of advanced non–small cell lung Cancer

SB Shi, XY Tang, J Tian, CX Chang, P Li… - Journal of …, 2014 - journals.lww.com
The aim of this study was to evaluate the safety and effectiveness of erlotinib plus DC/CIK in
maintenance therapy of advanced non–small cell lung cancer. After 4 cycles of the 2-drug …
被引用次数：44 相关文章

Efficacy of erlotinib plus dendritic cells and cytokine-induced killer cells in maintenance therapy of advanced non-small cell lung cancer

SB Shi, XY Tang, J Tian… - Journal of …, 2014 - pubmed.ncbi.nlm.nih.gov
The aim of this study was to evaluate the safety and effectiveness of erlotinib plus DC/CIK in
maintenance therapy of advanced non-small cell lung cancer. After 4 cycles of the 2-drug …

Efficacy of erlotinib plus dendritic cells and cytokine-induced killer cells in maintenance therapy of advanced non-small cell lung cancer.

SB Shi, XY Tang, J Tian, CX Chang, P Li… - … (Hagerstown, Md.: 1997 …, 2014 - europepmc.org
The aim of this study was to evaluate the safety and effectiveness of erlotinib plus DC/CIK in
maintenance therapy of advanced non-small cell lung cancer. After 4 cycles of the 2-drug …